An observational study in Epiretinal Membrane and Internal Limiting Membrane Wrinkling, sponsored by Changhua Christian Hospital. Completed at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2020-06-24.
Sponsored by Changhua Christian Hospital · Observational
To report cases who had received previous fovea-sparing internal limiting peeling membrane and developed secondary fovea epiretinal membrane contraction
Purpose: To report the rare complication of foveal epiretinal membrane (ERM) formation on residual internal limiting membrane (ILM) with severe contraction after previous fovea-sparing internal limiting membrane (ILM) peeling.
Study design: Retrospective case series Methods: We report patients who previously received fovea-sparing ILM peeling and complicated with foveal ERM formation and contraction.
120 studies on the registry are indexed under Epiretinal Membrane; 14 are open to participants now.
This study's enrollment of 3 is below the median of 60 across 45 observational studies indexed under Epiretinal Membrane.
Browse Epiretinal Membrane studies →Changhua Christian Hospital is the lead sponsor of 74 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients who developed secondary fovea epiretinal membrane after previous fovea-sparing internal limiting membrane surgery
Exclusion Criteria:
Patients developed secondary fovea epiretinal membrane
Procedure: fovea-sparing internal limiting membrane peeling
fovea-sparing internal limiting membrane peeling surgery
Visual acuity
Snellen visual acuity change
Time frame: 6 months
Optical coherence tomography finding
fovea change on optical coherence tomography
Time frame: 6 months
Plan to share: Undecided
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Changhua Christian Hospital